Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions
Full name: Tegretol (carbamazepine) 200 mg for tablet
- : Tegretol
- : carbamazepine
- : 200 mg
- : tablet
Name usage: ()
Authorised dose form:
Legal status of supply: Medicinal product subject to medical prescription
Domain: Human use
Resource status: active
Product classification:
1 of 1
Authorisation number: 22700AMX00173
Region:
Marketing authorisation holder: Fujinaga Pharmaceutical Co., Ltd.
Identifier:
Status: (2002-08-01T13:28:17Z)
Package 1 of 1
PMDA-PACKINSERTNO: placeholder2
Description:
Marketing status:
Pack size:
Package: 28 Bottle (PolyVinyl Chloride)
Containing:
Administrable Product (1 of 1)
Dose form:
Unit of presentation:
Route of administration:
IG © 2021+ Gravitate Health Project. Package hl7.eu.fhir.gh#0.1.0 based on FHIR 5.0.0. Generated 2024-05-02
Links: Table of Contents |
QA Report
The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.
This joint undertaking receives support from the EU H2020 research and innovation programme and EFPIA.
